Safety has not been established during pregnancy; benefit should outweigh risk.

AU TGA pregnancy category: B2
US FDA pregnancy category: Not formally assigned to a pregnancy category.

Comments:
-This drug is known to interfere with absorption of fat-soluble vitamins even in the presence of vitamin supplementation.
-This drug is essentially not absorbed systemically (less than 0.17% of the dose) and is not expected to cause fetal harm when administered during pregnancy at recommended doses.

Animal studies have not been reported. There are no controlled data in human pregnancy.

AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.

See references

This drug is a nonabsorbable resin which does not enter the mother's blood stream and therefore will not reach the infant via breast milk.

Use is generally considered acceptable; benefit to mother should outweigh risk to the infant.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: This drug is not absorbed systemically, however, the possibility of interference with absorption of fat soluble vitamins should be considered.

See references